Senseonics Holdings Inc
F:6L6
US |
Johnson & Johnson
NYSE:JNJ
|
Pharmaceuticals
|
|
US |
Estee Lauder Companies Inc
NYSE:EL
|
Consumer products
|
|
US |
Exxon Mobil Corp
NYSE:XOM
|
Energy
|
|
US |
Church & Dwight Co Inc
NYSE:CHD
|
Consumer products
|
|
US |
Pfizer Inc
NYSE:PFE
|
Pharmaceuticals
|
|
US |
American Express Co
NYSE:AXP
|
Financial Services
|
|
US |
Nike Inc
NYSE:NKE
|
Textiles, Apparel & Luxury Goods
|
|
US |
Visa Inc
NYSE:V
|
Technology
|
|
CN |
Alibaba Group Holding Ltd
NYSE:BABA
|
Retail
|
|
US |
3M Co
NYSE:MMM
|
Industrial Conglomerates
|
|
US |
JPMorgan Chase & Co
NYSE:JPM
|
Banking
|
|
US |
Coca-Cola Co
NYSE:KO
|
Beverages
|
|
US |
Target Corp
NYSE:TGT
|
Retail
|
|
US |
Walt Disney Co
NYSE:DIS
|
Media
|
|
US |
Mueller Industries Inc
NYSE:MLI
|
Machinery
|
|
US |
PayPal Holdings Inc
NASDAQ:PYPL
|
Technology
|
Utilize notes to systematically review your investment decisions. By reflecting on past outcomes, you can discern effective strategies and identify those that underperformed. This continuous feedback loop enables you to adapt and refine your approach, optimizing for future success.
Each note serves as a learning point, offering insights into your decision-making processes. Over time, you'll accumulate a personalized database of knowledge, enhancing your ability to make informed decisions quickly and effectively.
With a comprehensive record of your investment history at your fingertips, you can compare current opportunities against past experiences. This not only bolsters your confidence but also ensures that each decision is grounded in a well-documented rationale.
Do you really want to delete this note?
This action cannot be undone.
52 Week Range |
0.2591
0.72
|
Price Target |
|
We'll email you a reminder when the closing price reaches EUR.
Choose the stock you wish to monitor with a price alert.
Johnson & Johnson
NYSE:JNJ
|
US | |
Estee Lauder Companies Inc
NYSE:EL
|
US | |
Exxon Mobil Corp
NYSE:XOM
|
US | |
Church & Dwight Co Inc
NYSE:CHD
|
US | |
Pfizer Inc
NYSE:PFE
|
US | |
American Express Co
NYSE:AXP
|
US | |
Nike Inc
NYSE:NKE
|
US | |
Visa Inc
NYSE:V
|
US | |
Alibaba Group Holding Ltd
NYSE:BABA
|
CN | |
3M Co
NYSE:MMM
|
US | |
JPMorgan Chase & Co
NYSE:JPM
|
US | |
Coca-Cola Co
NYSE:KO
|
US | |
Target Corp
NYSE:TGT
|
US | |
Walt Disney Co
NYSE:DIS
|
US | |
Mueller Industries Inc
NYSE:MLI
|
US | |
PayPal Holdings Inc
NASDAQ:PYPL
|
US |
This alert will be permanently deleted.
Intrinsic Value
The intrinsic value of one 6L6 stock under the Base Case scenario is 0.15 EUR. Compared to the current market price of 0.27 EUR, Senseonics Holdings Inc is Overvalued by 46%.
The Intrinsic Value is calculated as the average of DCF and Relative values:
Valuation Backtest
Senseonics Holdings Inc
Uncover deeper insights with the Valuation Backtest. Learn how current stock valuations stack up against historical averages to gauge true investment potential.
Start backtest now and learn if your stock is truly undervalued or overvalued!
Stock is trading at its lowest valuation over the past 5 years.
To access the results of this valuation backtest, please register an account with us. Registration is quick and gives you instant access to insights on 3 stocks per week for free.
The backtest for 6L6 cannot be conducted due to limitations such as insufficient data or other constraints. Please select a different stock or adjust your settings.
Fundamental Analysis
Select up to 3 indicators:
Select up to 3 indicators:
Months
Months
Months
Months
Select up to 2 periods:
Revenue & Expenses Breakdown
Senseonics Holdings Inc
Balance Sheet Decomposition
Senseonics Holdings Inc
Current Assets | 130m |
Cash & Short-Term Investments | 109.5m |
Receivables | 6.6m |
Other Current Assets | 14m |
Non-Current Assets | 8.2m |
PP&E | 6.4m |
Other Non-Current Assets | 1.8m |
Current Liabilities | 17.3m |
Accounts Payable | 4.6m |
Accrued Liabilities | 12.7m |
Other Current Liabilities | 27k |
Non-Current Liabilities | 47.5m |
Long-Term Debt | 41.2m |
Other Non-Current Liabilities | 6.3m |
Earnings Waterfall
Senseonics Holdings Inc
Revenue
|
24m
USD
|
Cost of Revenue
|
-21.1m
USD
|
Gross Profit
|
2.9m
USD
|
Operating Expenses
|
-76.6m
USD
|
Operating Income
|
-73.8m
USD
|
Other Expenses
|
-6.7m
USD
|
Net Income
|
-80.5m
USD
|
Free Cash Flow Analysis
Senseonics Holdings Inc
USD | |
Free Cash Flow | USD |
6L6 Profitability Score
Profitability Due Diligence
Senseonics Holdings Inc's profitability score is 21/100. The higher the profitability score, the more profitable the company is.
Score
Senseonics Holdings Inc's profitability score is 21/100. The higher the profitability score, the more profitable the company is.
6L6 Solvency Score
Solvency Due Diligence
Senseonics Holdings Inc's solvency score is 46/100. The higher the solvency score, the more solvent the company is.
Score
Senseonics Holdings Inc's solvency score is 46/100. The higher the solvency score, the more solvent the company is.
Wall St
Price Targets
6L6 Price Targets Summary
Senseonics Holdings Inc
According to Wall Street analysts, the average 1-year price target for 6L6 is 1.13 EUR with a low forecast of 0.24 EUR and a high forecast of 2.07 EUR.
Dividends
Current shareholder yield for SENS is .
Shareholder yield represents the total return a company provides to its shareholders, calculated as the sum of dividend yield, buyback yield, and debt paydown yield. What is shareholder yield?
Ownership
SENS Insider Trading
Buy and sell transactions by insiders
Period | Sold | Bought | Net |
---|---|---|---|
3 Months |
|
|
|
6 Months |
|
|
|
9 Months |
|
|
|
12 Months |
|
|
|
Profile
Country
Industry
Market Cap
Dividend Yield
Description
Senseonics Holdings, Inc. engages in the design, development, and commercialization of an implantable continuous glucose monitoring system for people with diabetes. The company is headquartered in Germantown, Maryland and currently employs 121 full-time employees. The company went IPO on 2015-03-04. The firm is focused on the development and manufacturing of glucose monitoring products designed to transform lives in the global diabetes community. Its Eversense, Eversense XL, and Eversense E3 continuous glucose monitoring (CGM) systems are designed to continually measure glucose levels in people with diabetes via an under-the-skin sensor, a removable and rechargeable smart transmitter, and a mobile application for real-time diabetes monitoring and management for a period of up to six months. The company is also developing its Gemini product variation to allow for a two-in-one glucose monitoring system combining the functionality of CGM and Flash Glucose Monitoring (FGM), in an implantable sensor that may be utilized with a smart transmitter to get continuous glucose readings and alerts or be utilized through a swipe over the sensor with a smart phone to get on-demand glucose readings without a smart transmitter.
Contact
IPO
Employees
Officers
The intrinsic value of one 6L6 stock under the Base Case scenario is 0.15 EUR.
Compared to the current market price of 0.27 EUR, Senseonics Holdings Inc is Overvalued by 46%.